Merck KGaA Says New Meds Will Add €2bn Sales

 
• By Kevin Grogan
  
Euro_Notes_500
Merck hopeful of €2bn from pipeline sales by 2022 • Source: Shutterstock

More from Clinical Trials

More from R&D